The Ozempic segment held the largest share of 51.9% in 2025
Mioduchoski, FNP-BC explains that many patients begin asking about peptide therapy after achieving meaningful weight loss
Fortunately, Semaglutide has emerged as a promising solution
Patients considering Ozempic should discuss potential side effects and appropriate usage with their healthcare providers to ensure the best possible outcomes
This heightened demand for the drug also found its way into the black-market arena, often leading to serious adverse side effects, hospitalizations, and reactions resulting from exposure to contaminated products that bypassed the vetting for safety, quality, and efficacy of the product
Exenatide, one of the first approved, extended the half-life enough to allow twice-daily injections